[{"_id":"556b2aecfac443afdd394496","決算期":"2015年3月期","証券コード":"4559","会社名":"ゼリア新薬工業(株)【4559】","会計方式":"日本方式","決算発表日":"2015年5月8日","決算月数":"12か月","売上高":"61,012百万円","営業利益":"2,678百万円","経常利益":"2,770百万円","当期利益":"2,557百万円","EPS（一株当たり利益）":"48.15円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,178.00円","総資産":"96,268百万円","自己資本":"62,570百万円","資本金":"6,593百万円","有利子負債":"22,208百万円","自己資本比率":"65.0%","ROA（総資産利益率）":"2.61%","ROE（自己資本利益率）":"4.22%","総資産経常利益率":"2.83%","日付":"2015-05-31T15:38:20.392Z"},{"_id":"556b2aecfac443afdd39449a","決算期":"2014年3月期","証券コード":"4559","会社名":"ゼリア新薬工業(株)【4559】","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"61,996百万円","営業利益":"6,790百万円","経常利益":"6,803百万円","当期利益":"5,277百万円","EPS（一株当たり利益）":"115.01円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,105.78円","総資産":"99,493百万円","自己資本":"58,734百万円","資本金":"6,593百万円","有利子負債":"26,460百万円","自己資本比率":"59.0%","ROA（総資産利益率）":"5.94%","ROE（自己資本利益率）":"11.06%","総資産経常利益率":"7.66%","日付":"2015-05-31T15:38:20.392Z"},{"_id":"556b2aecfac443afdd3944a0","決算期":"2013年3月期","証券コード":"4559","会社名":"ゼリア新薬工業(株)【4559】","会計方式":"日本方式","決算発表日":"2013年5月16日","決算月数":"12か月","売上高":"53,317百万円","営業利益":"4,611百万円","経常利益":"4,676百万円","当期利益":"3,982百万円","EPS（一株当たり利益）":"96.32円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"888.41円","総資産":"78,246百万円","自己資本":"36,726百万円","資本金":"6,593百万円","有利子負債":"30,915百万円","自己資本比率":"46.9%","ROA（総資産利益率）":"5.19%","ROE（自己資本利益率）":"11.87%","総資産経常利益率":"6.09%","日付":"2015-05-31T15:38:20.393Z"}]